Fundraising FoxMedTex Ventures LLC — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
Voyager Biomedical develops VenaSure, an implanted porous titanium device that creates a palpable access window to guide reliable cannulation of AV fistulas for hemodialysis patients.
HardwareHealthtechMedical DevicesHouston, US
Marcus Penna(Executive Officer, Director)Monica Klos(Executive Officer)inLinda Spain(Executive Officer, Director)
BoardBruce Shook(Director)
Board seatTrevor UhlAshok Gowda· per SEC Form D · $9.8M raise · filed Apr 2025
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.